Primary study · included by 1 review
Predictors for future clinically significant pain in patients with temporomandibular disorder: A prospective cohort study.
Forssell 2016 · Forssell H, Kauko T, Kotiranta U, et al. · European journal of pain (London, England) · 2017
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Pain intensity/course of TMD pain over follow-up (adjusted analysis) Prognostic factor: Number of disability days vs Lower level or absence of the factor (reference not specified) · Follow-up 6 months to 11 years across studies | OR 1.079 [0.939, 1.239] | 2 studies | Very low |
Pain intensity/course of TMD pain over follow-up (adjusted analysis) Prognostic factor: Age vs Lower level or absence of the factor (reference not specified) · Follow-up 6 months to 11 years across studies | OR 1 [0.982, 1.018] | 2 studies | Moderate |
Pain intensity/course of TMD pain over follow-up (adjusted analysis) Prognostic factor: Pain intensity vs Lower level or absence of the factor (reference not specified) · Follow-up 6 months to 11 years across studies | OR 1.16 [0.786, 1.711] | 3 studies | Very low |
Pain intensity/course of TMD pain over follow-up (adjusted analysis) Prognostic factor: Self-efficacy vs Lower level or absence of the factor (reference not specified) · Follow-up 6 months to 11 years across studies | OR 0.971 [0.593, 1.59] | 2 studies | Very low |
Pain intensity/course of TMD pain over follow-up (adjusted analysis) Prognostic factor: Gender vs Lower level or absence of the factor (reference not specified) · Follow-up 6 months to 11 years across studies | OR 1.121 [0.474, 2.652] | 2 studies | Low |
Also linked to PM41760141-P3-O2, PM41760141-P4-O2, PM41760141-P2-O2, which does not match a current question in this review.
1 including review in total.